Cargando…

Effect of magnesium supplementation in improving hyperandrogenism, hirsutism, and sleep quality in women with polycystic ovary syndrome: A randomized, placebo‐controlled clinical trial

BACKGROUND AND AIMS: Polycystic ovary syndrome (PCOS) is one of the common endocrine disorders in women, which causes numerous symptoms in women. The relationship of many micronutrients with this syndrome has been investigated. This study was conducted to examine the effects of magnesium supplementa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gholizadeh‐Moghaddam, Mahsa, Ghasemi‐Tehrani, Hatav, Askari, Gholamreza, Jaripur, Mahsima, Clark, Cain C. T., Rouhani, Mohammad Hossein
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9798963/ https://www.ncbi.nlm.nih.gov/pubmed/36620514 http://dx.doi.org/10.1002/hsr2.1013

Ejemplares similares

The effects of magnesium supplementation on abnormal uterine bleeding, alopecia, quality of life, and acne in women with polycystic ovary syndrome: a randomized clinical trial
por: Jaripur, Mahsima, et al.
Publicado: (2022)

Effects of Probiotic Supplementation on Pancreatic β-cell Function and C-reactive Protein in Women with Polycystic Ovary Syndrome: A Randomized Double-blind Placebo-controlled Clinical Trial
por: Shoaei, Tanaz, et al.
Publicado: (2015)

The prevalence of idiopathic hirsutism and polycystic ovary syndrome in the Tehran Lipid and Glucose Study
por: Tehrani, Fahimeh Ramezani, et al.
Publicado: (2011)

Hyperprolactinemia and Hirsutism in Patients Without Polycystic Ovary Syndrome
por: Tirgar-Tabari, Soudabeh, et al.
Publicado: (2016)

N-Acetylcysteine as an Adjuvant to Letrozole for Induction of Ovulation in Infertile Patients with Polycystic Ovary Syndrome
por: Mostajeran, Fateme, et al.
Publicado: (2018)

Evaluation of Changes in Levels of Hyperandrogenism, Hirsutism and Menstrual Regulation After a Period of Aquatic High Intensity Interval Training in Women with Polycystic Ovary Syndrome
por: Samadi, Zeinab, et al.
Publicado: (2019)

Reply to: Hyperprolactinemia and Hirsutism in Patients without Polycystic Ovary Syndrome
por: Saceda-Corralo, David, et al.
Publicado: (2017)

Clinical Characteristics of Hyperandrogenism Include Hirsutism, Polycystic Ovary Syndrome, and Acne: Association with Psychiatric Disease in Women -A Nationwide Population-Based Cohort Study in Taiwan
por: Wang, Tsan-Min, et al.
Publicado: (2022)

SAT-224 Polycystic Ovary Syndrome with Adrenal Hyperandrogenemia and Refractory Hirsutism
por: Parveen, Sanober, et al.
Publicado: (2019)

The effect of calcium and vitamin D supplementation on menstrual cycle, body mass index and hyperandrogenism state of women with poly cystic ovarian syndrome
por: Tehrani, Hatav Ghasemi, et al.
Publicado: (2014)

The Relationship Between Hearing Thresholds and Hyperandrogenism in Polycystic Ovary Syndrome
por: Turan, Mahfuz, et al.
Publicado: (2016)

Hyperandrogenism correlates with psychological symptoms in adolescents with polycystic ovary syndrome
por: Donbaloğlu, Zeynep, et al.
Publicado: (2022)

Low intakes of dietary fiber and magnesium are associated with insulin resistance and hyperandrogenism in polycystic ovary syndrome: A cohort study
por: Cutler, Dylan A., et al.
Publicado: (2019)

Comparison of the effects of metformin, flutamide plus oral contraceptives, and simvastatin on the metabolic consequences of polycystic ovary syndrome
por: Mehrabian, Ferdous, et al.
Publicado: (2016)

Association between Lipid Accumulation Product and Hirsutism in Patients with Polycystic Ovary Syndrome
por: Oliveira, Flávia Ribeiro de, et al.
Publicado: (2016)

Identification of Differentially Expressed MicroRNAs in the Ovary of Polycystic Ovary Syndrome with Hyperandrogenism and Insulin Resistance
por: Lin, Lin, et al.
Publicado: (2015)

Metformin Therapy Decreases Hyperandrogenism and Ovarian Volume in Women with Polycystic Ovary Syndrome
por: Farimani Sanoee, Marzieh, et al.
Publicado: (2011)

Ovarian Aging-Like Phenotype in the Hyperandrogenism-Induced Murine Model of Polycystic Ovary
por: Rezvanfar, Mohammad Amin, et al.
Publicado: (2014)

Are Psychosocial Consequences of Obesity and Hyperandrogenism Present in Adolescent Girls with Polycystic Ovary Syndrome?
por: Zachurzok, Agnieszka, et al.
Publicado: (2018)

Telomere Length Differently Associated to Obesity and Hyperandrogenism in Women With Polycystic Ovary Syndrome
por: Velazquez, Mariela Edith, et al.
Publicado: (2021)

Effect of soy isoflavones supplementation on migraine characteristics, mental status and calcitonin gene-related peptide (CGRP) levels in women with migraine: results of randomised controlled trial
por: Babapour, Maedeh, et al.
Publicado: (2022)

Surgical treatment of post-menopausal ovarian hyperandrogenism improves glucometabolic profile alongside clinical hirsutism
por: De Taddeo, Sofia, et al.
Publicado: (2023)

Effects of hyperandrogenism on metabolic abnormalities in patients with polycystic ovary syndrome: a meta-analysis
por: Yang, Rui, et al.
Publicado: (2016)

Correlation between biochemical and clinical hyperandrogenism parameter in polycystic ovary syndrome in relation to age
por: Guo, Zaixin, et al.
Publicado: (2023)

Non-alcoholic fatty liver disease is associated with hyperandrogenism in women with polycystic ovary syndrome
por: Hong, So-hyeon, et al.
Publicado: (2023)

Adiponectin and Its Receptors in the Ovary: Further Evidence for a Link between Obesity and Hyperandrogenism in Polycystic Ovary Syndrome
por: Comim, Fabio V., et al.
Publicado: (2013)

Effects of tanshinone on hyperandrogenism and the quality of life in women with polycystic ovary syndrome: protocol of a double-blind, placebo-controlled, randomised trial
por: Shen, Wenjuan, et al.
Publicado: (2013)

Assessment of Health-Related Quality of Life in Patients with Idiopathic Hirsutism Compared to Patients with Polycystic Ovary Syndrome
por: Canat, Muhammed Masum, et al.
Publicado: (2023)

Follicular hyperandrogenism and insulin resistance in polycystic ovary syndrome patients with normal circulating testosterone levels
por: Li, Andi, et al.
Publicado: (2018)

Effect of “DXB-2030,” a Polyherbal Formulation, on Experimental Polycystic Ovary Syndrome Associated with Hyperandrogenism
por: Azeemuddin, Mohammed, et al.
Publicado: (2019)

Serum calprotectin levels as markers of inflammation, insulin resistance and hyperandrogenism in women with polycystic ovary syndrome
por: Hancerliogullari, Necati, et al.
Publicado: (2022)

An ovarian Leydig cell tumor of ultrasound negative in a postmenopausal woman with hirsutism and hyperandrogenism: A case report
por: Chen, Min, et al.
Publicado: (2018)

Association between biochemical hyperandrogenism parameters and modified Ferriman-Gallwey score in patients with hirsutism in Basrah (Southern Iraq)
por: Hussein, Rudha Naser, et al.
Publicado: (2021)

Lack of Hirsutism in an XX Woman With History of Hyperandrogenism and Oligomenorrhea: Two Coexisting Disorders or Novel Syndrome of Androgen Insensitivity?
por: Ueda, Masako, et al.
Publicado: (2021)

Cardiovascular disease risk in women with hyperandrogenism, oligomenorrhea/menstrual irregularity or polycystic ovaries (components of polycystic ovary syndrome): a systematic review and meta-analysis
por: Lo, Andre C Q, et al.
Publicado: (2023)

Animal models of hyperandrogenism and ovarian morphology changes as features of polycystic ovary syndrome: a systematic review
por: Paixão, Larissa, et al.
Publicado: (2017)

Hyperandrogenism and Metabolic Syndrome Are Associated With Changes in Serum-Derived microRNAs in Women With Polycystic Ovary Syndrome
por: Sørensen, Anja E., et al.
Publicado: (2019)

Effect of DHT-Induced Hyperandrogenism on the Pro-Inflammatory Cytokines in a Rat Model of Polycystic Ovary Morphology
por: Krishnan, Abhaya, et al.
Publicado: (2020)

Elevated plasma pentraxin-3 in polycystic ovary syndrome is associated with hyperandrogenism: a case-control study
por: Jin, Congcong, et al.
Publicado: (2021)

Cardiovascular, anthropometric, metabolic and hormonal profiling of normotensive women with polycystic ovary syndrome with and without biochemical hyperandrogenism
por: Kałużna, Małgorzata, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_d91currvkuedbafumr04p282av